AIM ImmunoTech (NYSE:AIM – Get Free Report) will issue its quarterly earnings data on Tuesday, April 2nd. AIM ImmunoTech Trading Up 6.3 % Shares of NYSE AIM opened at $0.47 on Monday. AIM ImmunoTech has a one year low of $0.32 and a one year high of $0.75. The firm has a market capitalization of […]
AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Insider and Institutional Ownership 12.8% of AIM […]